Skip to main content
. 2017 Aug;79(3):313–321. doi: 10.18999/nagjms.79.3.313

Table 3.

The mean difference of the change rate for primary outcome and secondary outcomesa)

Measured values,
mean (SD)
Change rate from
baseline to
6 months (%),
mean (SD)
ΔIG

ΔCGb)
p
Baseline 6 months
MMAS-8 (score) Intervention 6.15 (1.10) 6.66 (1.37) 11.8 (29.9) –2.4 0.78
Control 5.86 (1.55) 6.26 (1.28) 14.2 (39.0)
Functional HL (score) Intervention 2.96 (0.70) 3.12 (0.77) 15.0 (68.7) –0.5 0.98
Control 2.99 (0.77) 3.27 (0.48) 15.5 (29.7)
Communicative HL (score) Intervention 3.15 (0.49) 2.84 (0.52) – 8.5 (24.4) –6.5 0.32
Control 3.36 (0.52) 3.25 (0.53) – 2.1 (14.3)
Critical HL (score) Intervention 2.60 (0.37) 2.50 (0.71) – 2.2 (30.8) –1.7 0.85
Control 2.67 (0.46) 2.61 (0.59) – 0.4 (25.2)
Total HL (score) Intervention 2.93 (0.31) 2.84 (0.58) – 2.1 (21.1) –4.8 0.39
Control 3.03 (0.46) 3.08 (0.36) 2.7 (12.6)
SESD (score) Intervention 23.4 (3.7) 23.1 (3.5) – 0.6 (10.8) –10.7 0.20
Control 22.8 (5.6) 23.7 (3.8) 10.1 (33.4)
HbA1c (%) Intervention 9.4 (2.2) 6.6 (0.9) – 26.9 (15.4) –6.9 0.29
Control 9.4 (2.0) 7.3 (2.2) – 20.1 (23.7)

Abbreviations: IG, intervention group; CG, control group; MMAS–8, morisky medication adherence scale 8–items; HL, health literacy; SESD, self–efficacy scale for diabetes self care; A1C, glycosylated hemoglobin.

a) 20 in the intervention group and 19 in the control group were included in the analysis.

b) The mean difference of the change rate from baseline to 6 months between intervention and control groups.